Point Of Care Diagnostics Market By Product (glucose Testing, Hb1 Ac Testing, Infectious Disease Testing, Coagulation, Fertility, Cardiac Markers, Primary Care Systems, Hematology, Decentralized Clinical Chemistry, Feces, Blood Gas/electrolytes, Ambulatory Chemistry, Urinalysis & Drug Abuse Testing) And End User (clinics, Hospitals, Assisted Living Healthcare Facilities, Laboratory & Other End Users)- Global Industry Analysis And Forecast To 2023

Published On : June 2018 Pages : 190 Category: In-Vitro Diagnostics Report Code : HC061046

Industry Outlook and Trend Analysis

The Point of Care (PoC) Diagnostics Market was worth USD 17.61 billion in the year of 2014 and is expected to reach approximately USD 41.69 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.05% during the forecast period. Hospitals and other healthcare foundations, trying to give viable and quick indicative outcomes, are holding fast to point of care tests therefore affecting industrial development. Enhancement in innovation and the resultant presentation of practical and top notch therapeutic arrangements focused at accomplishing lab computerization and scaling down are expected to serve the worldwide point of care diagnostics market as a vital driver. Additionally, expanding levels of consciousness in patients are anticipated to demonstrate basic for the development by virtue of the way that patients, particularly the ones experiencing chronic illnesses, for example, diabetes, are energetically taking an interest in the move relating to the execution of point of care analytic practices. Also, healthcare practitioners have been seen to be paying more attention towards use of point of care symptomatic empowered therapeutic gadgets and consumables in this way bringing about to developing reception and interest for POCT arrangements. Improvement of information technology relating to health care frameworks plays an inescapable part in the advancement of the point of care diagnostics market. The advent of medicinal services data frameworks, for example, electronic wellbeing records EHR has to a great extent expanded the entrance rates of these tests as a blend of the previously mentioned empowers significant computerization of diagnostics capacities of any medical facility. Developing commonness of target infections combined with ascend in the geriatric populace base which is more inclined to ailment improvement and need home care and observing are attributive to affect the item request impressively finished the gauge time frame.

Application Outlook and Trend Analysis

In 2015 Blood glucose testing POC meters represented the biggest offer of more than 40 percent because of the sheer volume of these tests marketed by virtue of their high utilization. Besides, the non-proficient status of testing prerequisite related with glucose biosensors likewise converts into the tests being utilized as a part of an upgraded number of healthcare patient settings, be it in laboratories, home, clinics or assisted living focuses subsequently, driving the fragment demand. This fragment is generally more immersed as far as market potential when contrasted with the other POC sections and consequently isn't probably going to witness any sudden development spurts over the figure time frame. Nonetheless, the section is anticipated to keep up its overwhelming position over the coming couple of years. POC cardiac marker testing portions is anticipated to encounter development sought after at a moderately speedier CAGR over the estimate time frame despite the fact that the section in the present situation represents a smaller offer of income. The essential calculate driving R&D the portion is the way that cardiovascular sickness related deaths have expanded by more than 40 percent in the course of recent decades. In endeavors to give early determination and remedial observing for heart patients, the industry pioneers have contributed noteworthy resources for the advancement and commercialization of various cardiovascular marker POC tests. Additionally improved commercialization by the members is clear finished the coming years which can be relied upon to drive development in this section at a quicker pace than whatever is left of the point of care products.

End User Outlook and Trend Analysis

In 2015 Centers commanded as for income age because of higher utilization of these tests in the facilities for conclusion of a few contaminations and observing of malady movement by evaluation of side effects and different parameters. Home healthcare attributable to cost viability and level of comfort it gives to the patients is foreseen to enable the clinicians in tending to social insurance difficulties and take choices right away. As the accentuation of healthcare is moving towards early recognition and counteractive action of infections, the point-of-care diagnostics based home social insurance portion is anticipated to witness lucrative development amid the figure time frame.

Regional Outlook and Trend Analysis

In 2015 North America held the biggest piece of the overall industry of more than 43 percent due to the existence of high levels of disease prevalence in the district combined with great government controls and activities relating to improvement of social insurance framework. In addition, existence of high consciousness levels among the patients and the doctors relating to early ailment conclusion is strong for the biggest offer of district in the modern income. Asia Pacific is anticipated to be the most alluring regional market space, attributable to the existence of neglected medical requirements and continually enhancing social insurance framework, developing medicinal awareness, and ascend in per capita wage levels in creating economies of including China and India.

Competitive Insights

The major players in the market are Siemens Healthineers, Alere Inc, Abbott Laboratories, Roche Diagnostics India Pvt Ltd, BioMérieux and Danaher Corporation. A large portion of the organizations offer their items through the wholesalers of medical equipment that work for various areas and in this manner represent significant rivalry regarding dispersion system and market existence. Market entities are engaged with improvement and commercialization of more advanced patient testing items which are relied upon to upgrade the interest for POC gadgets and along these lines drive industrial development.

The global Point of Care (PoC) Diagnostics Market is segmented as follows-

By Product:

  • Feces
  • Infectious Disease Testing
  • Glucose Testing
  • Blood Gas/Electrolytes
  • Infectious Disease Testing
    • TB and drug-resistant TB POC
    • HIV POC
    • Pneumonia or Streptococcus associated infections
    • Influenza/Flu POC
    • Clostridium difficile POC
    • MRSA POC
    • HBV POC
    • HSV POC
    • HPV POC
    • Respiratory syncytial virus (RSV) POC
    • HCV POC
    • Others
  • Ambulatory Chemistry
  • Decentralized Clinical Chemistry
  • Coagulation
  • Drug Abuse Testing
  • Primary care systems
  • Urinalysis
  • Cardiac markers
  • Hb1 Ac Testing
  • Hematology

By End User:

  • Laboratory
  • Clinics
  • Assisted Living Healthcare Facilities
  • Hospitals
  • Others

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2012 and forecast from 2013 to 2022?
  • What will be the industry market growth from 2013 to 2022?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

 

Market Classification

·         Point of Care Diagnostics Market, By Product, Estimates and Forecast, 2014-2023 ($Million)

·         Glucose Testing

·         Hb1 Ac Testing

·         Infectious Disease Testing

·         Coagulation

·         Fertility

·         Cardiac markers

·         Primary care systems

·         Hematology

·         Decentralized Clinical Chemistry

·         Feces

·         Blood Gas/Electrolytes

·         Ambulatory Chemistry

·         Urinalysis

·         Drug Abuse Testing

·         Point of Care Diagnostics Market, By End User, Estimates and Forecast, 2014-2023 ($Million)

·         Clinics

·         Hospitals

·         Assisted Living Healthcare Facilities

·         Laboratory

·         Other End Users

·         Point of Care Diagnostics Market, By Region, Estimates and Forecast, 2014-2023 ($Million)

·         North America

§  North America Point of Care Diagnostics Market, By Country

o    U.S. Point of Care Diagnostics Market

o    Canada Point of Care Diagnostics Market

o    Mexico Point of Care Diagnostics Market

·         Europe

§  Europe Point of Care Diagnostics Market, By Country

o    Germany Point of Care Diagnostics Market

o    UK Point of Care Diagnostics Market

o    France Point of Care Diagnostics Market

o    Russia Point of Care Diagnostics Market

o    Italy Point of Care Diagnostics Market

o    Rest of Europe Point of Care Diagnostics Market

·         Asia-Pacific

§  Asia-Pacific Point of Care Diagnostics Market, By Country

o    China Point of Care Diagnostics Market

o    Japan Point of Care Diagnostics Market

o    South Korea Point of Care Diagnostics Market

o    India Point of Care Diagnostics Market

o    Southeast Asia Point of Care Diagnostics Market

o    Rest of Asia-Pacific Point of Care Diagnostics Market

·         South America

§  South America Point of Care Diagnostics Market

o    Brazil Point of Care Diagnostics Market

o    Argentina Point of Care Diagnostics Market

o    Columbia Point of Care Diagnostics Market

o    South Africa Point of Care Diagnostics Market

o    Rest of South America Point of Care Diagnostics Market

·         Middle East and Africa

§  Middle East and Africa Point of Care Diagnostics Market

o    Saudi Arabia Point of Care Diagnostics Market

o    UAE Point of Care Diagnostics Market

o    Egypt Point of Care Diagnostics Market

o    Nigeria Point of Care Diagnostics Market

o    South Africa Point of Care Diagnostics Market

o    Rest of MEA Point of Care Diagnostics Market

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

1.2.1.  Secondary Research

1.2.2.  Primary Research

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.       North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2014-2023)

4.1.2.  Canada Market States and Outlook (2014-2023)

4.1.3.  Mexico Market States and Outlook (2014-2023)

4.2.       Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2014-2023)

4.2.2.  France Market States and Outlook (2014-2023)

4.2.3.  UK Market States and Outlook (2014-2023)

4.2.4.  Russia Market States and Outlook (2014-2023)

4.2.5.  Italy Market States and Outlook (2014-2023)

4.2.6.  Rest of Europe Market States and Outlook (2014-2023)

4.3.       Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2014-2023)

4.3.2.  Japan Market States and Outlook (2014-2023)

4.3.3.  Korea Market States and Outlook (2014-2023)

4.3.4.  India Market States and Outlook (2014-2023)

4.3.5.  Rest of Asia-Pacific Market States and Outlook (2014-2023)

4.4.       South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2014-2023)

4.4.2.  Argentina Market States and Outlook (2014-2023)

4.4.3.  Columbia Market States and Outlook (2014-2023)

4.4.4.  Rest of South America Market States and Outlook (2014-2023)

4.5.       Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2014-2023)

4.5.2.  UAE Market States and Outlook (2014-2023)

4.5.3.  Egypt Market States and Outlook (2014-2023)

4.5.4.  Nigeria Market States and Outlook (2014-2023)

4.5.5.  South Africa Market States and Outlook (2014-2023)

4.5.6.  Rest of MEA Market States and Outlook (2014-2023)

5.       Point of Care Diagnostics Market, By Product

5.1.       Introduction

5.2.       Global Point of Care Diagnostics Revenue and Market Share by Product (2014-2018)

5.2.1.  Global Point of Care Diagnostics Revenue and Revenue Share by Product (2014-2018)

5.3.       Glucose Testing

5.3.1.  Global Glucose Testing Revenue and Growth Rate (2014-2018)

5.4.       Hb1 Ac Testing

5.4.1.  Global Hb1 Ac Testing Revenue and Growth Rate (2014-2018)

5.5.       Infectious Disease Testing

5.5.1.  Global Infectious Disease Testing Revenue and Growth Rate (2014-2018)

5.6.       Coagulation

5.6.1.  Global Coagulation Revenue and Growth Rate (2014-2018)

5.7.       Fertility

5.7.1.  Global Fertility Revenue and Growth Rate (2014-2018)

5.8.       Cardiac markers

5.8.1.  Global Cardiac markers Revenue and Growth Rate (2014-2018)

5.9.       Primary care systems

5.9.1.  Global Primary care systems Revenue and Growth Rate (2014-2018)

5.10.    Hematology

5.10.1.      Global Hematology Revenue and Growth Rate (2014-2018)

5.11.    Decentralized Clinical Chemistry

5.11.1.      Global Decentralized Clinical Chemistry Revenue and Growth Rate (2014-2018)

5.12.    Feces

5.12.1.      Global Feces Revenue and Growth Rate (2014-2018)

5.13.    Blood Gas/Electrolytes

5.13.1.      Global Blood Gas/Electrolytes Revenue and Growth Rate (2014-2018)

5.14.    Ambulatory Chemistry

5.14.1.      Global Ambulatory Chemistry Revenue and Growth Rate (2014-2018)

5.15.    Urinalysis

5.15.1.      Global Urinalysis Revenue and Growth Rate (2014-2018)

5.16.    Drug Abuse Testing

5.16.1.      Global Drug Abuse Testing Revenue and Growth Rate (2014-2018)

6.       Point of Care Diagnostics Market, By End User

6.1.       Introduction

6.2.       Global Point of Care Diagnostics Revenue and Market Share by End User (2014-2018)

6.2.1.  Global Point of Care Diagnostics Revenue and Revenue Share by End User (2014-2018)

6.3.       Clinics

6.3.1.  Global Clinics Revenue and Growth Rate (2014-2018)

6.4.       Hospitals

6.4.1.  Global Hospitals Revenue and Growth Rate (2014-2018)

6.5.       Assisted Living Healthcare Facilities

6.5.1.  Global Assisted Living Healthcare Facilities Revenue and Growth Rate (2014-2018)

6.6.       Laboratory

6.6.1.  Global Laboratory Revenue and Growth Rate (2014-2018)

6.7.       Other End Users

6.7.1.  Global Other End Users Revenue and Growth Rate (2014-2018)

7.       Point of Care Diagnostics Market, By Region

7.1.       Introduction

7.2.       Global Point of Care Diagnostics Revenue and Market Share by Regions

7.2.1.  Global Point of Care Diagnostics Revenue by Regions (2014-2018)

7.3.       North America Point of Care Diagnostics by Countries

7.3.1.  North America Point of Care Diagnostics Revenue and Growth Rate (2014-2018)

7.3.2.  North America Point of Care Diagnostics Revenue by Countries (2014-2018)

7.3.3.  North America Point of Care Diagnostics Revenue (Million USD) by Countries (2014-2018)

7.3.4.  U.S.

7.3.4.1.    United States Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.5.  Canada

7.3.5.1.    Canada Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.3.6.  Mexico

7.3.6.1.    Mexico Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.       Europe Point of Care Diagnostics by Countries

7.4.1.  Europe Point of Care Diagnostics Revenue and Growth Rate (2014-2018)

7.4.2.  Europe Point of Care Diagnostics Revenue by Countries (2014-2018)

7.4.3.  Europe Point of Care Diagnostics Revenue (Million USD) by Countries (2014-2018)

7.4.4.  Germany

7.4.4.1.    Germany Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.5.  UK

7.4.5.1.    UK Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.6.  France

7.4.6.1.    France Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.7.  Russia

7.4.7.1.    Russia Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.8.  Italy

7.4.8.1.    Italy Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.4.9.  Rest of Europe

7.4.9.1.    Rest of Europe Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.       Asia-Pacific

7.5.1.  Asia-Pacific Point of Care Diagnostics Revenue and Growth Rate (2014-2018)

7.5.2.  Asia-Pacific Point of Care Diagnostics Revenue by Countries (2014-2018)

7.5.3.  Asia-Pacific Point of Care Diagnostics Revenue (Million USD) by Countries (2014-2018)

7.5.4.  China

7.5.4.1.    China Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.  Japan

7.5.5.1.    Japan Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.5.2.     

7.5.6.  Korea

7.5.6.1.    Korea Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.7.  India

7.5.7.1.    India Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.8.  Southeast Asia

7.5.8.1.    Southeast Asia Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.5.9.  Rest of Asia-Pacific

7.5.9.1.    Rest of Asia-Pacific Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.       South America

7.6.1.  South America Point of Care Diagnostics Revenue and Growth Rate (2014-2018)

7.6.2.  South America Point of Care Diagnostics Revenue by Countries (2014-2018)

7.6.3.  South America Point of Care Diagnostics Revenue (Million USD) by Countries (2014-2018)

7.6.4.  Brazil

7.6.4.1.    Brazil Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.5.  Argentina

7.6.5.1.    Argentina Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.6.  Columbia

7.6.6.1.    Columbia Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.6.7.  Rest of South America

7.6.7.1.    Rest of South America Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.       Middle East and Africa

7.7.1.  Middle East and Africa Point of Care Diagnostics Revenue and Growth Rate (2014-2018)

7.7.2.  Middle East and Africa Point of Care Diagnostics Revenue by Countries (2014-2018)

7.7.3.  Middle East and Africa Point of Care Diagnostics Revenue (Million USD) by Countries (2014-2018)

7.7.4.  Saudi Arabia

7.7.4.1.    Saudi Arabia Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.5.  United Arab Emirates

7.7.5.1.    United Arab Emirates Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.6.  Egypt

7.7.6.1.    Egypt Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.7.  Nigeria

7.7.7.1.    Nigeria Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.8.  South Africa

7.7.8.1.    South Africa Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.    Rest of Middle East and Africa Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2014-2018)

8.       Company Profiles

8.1.       Roche Diagnostics

8.1.1.  Business Overview

8.1.2.  Product Portfolio

8.1.3.  Strategic Developments

8.1.4.  Revenue and Market Share

8.2.       Abbott Diagnostics Inc

8.2.1.  Business Overview

8.2.2.  Product Portfolio

8.2.3.  Strategic Developments

8.2.4.  Revenue and Market Share

8.3.       Siemens Healthcare

8.3.1.  Business Overview

8.3.2.  Product Portfolio

8.3.3.  Strategic Developments

8.3.4.  Revenue and Market Share

8.4.       Danaher Corporation (Beckman Coulter Inc. and Radiometer)

8.4.1.  Business Overview

8.4.2.  Product Portfolio

8.4.3.  Strategic Developments

8.4.4.  Revenue and Market Share

8.5.       bioMerieux

8.5.1.  Business Overview

8.5.2.  Product Portfolio

8.5.3.  Strategic Developments

8.5.4.  Revenue and Market Share

8.6.       Abaxis, Inc.

8.6.1.  Business Overview

8.6.2.  Product Portfolio

8.6.3.  Strategic Developments

8.6.4.  Revenue and Market Share

8.7.       Alere, Inc.

8.7.1.  Business Overview

8.7.2.  Product Portfolio

8.7.3.  Strategic Developments

8.7.4.  Revenue and Market Share

8.8.       Qiagen N.V.

8.8.1.  Business Overview

8.8.2.  Product Portfolio

8.8.3.  Strategic Developments

8.8.4.  Revenue and Market Share

8.9.       Spectral Diagnostics

8.9.1.  Business Overview

8.9.2.  Product Portfolio

8.9.3.  Strategic Developments

8.9.4.  Revenue and Market Share

8.10.    Instrumentation Laboratory

8.10.1.      Business Overview

8.10.2.      Product Portfolio

8.10.3.      Strategic Developments

8.10.4.      Revenue and Market Share

9.       Global Point of Care Diagnostics Market Competition, by Manufacturer

9.1.       Global Point of Care Diagnostics Revenue and Market Share by Manufacturer (2016-2017)

9.2.       Global Point of Care Diagnostics Price by Region (2016-2017)

9.3.       Top 5 Point of Care Diagnostics Manufacturer Market Share

9.4.       Market Competition Trend

10.   Point of Care Diagnostics Market Forecast (2018-2023)

10.1.    Global Point of Care Diagnostics Revenue (Millions USD) and Growth Rate (2018-2023)

10.2.    Point of Care Diagnostics Market Forecast by Regions (2018-2023)

10.2.1.      North America Point of Care Diagnostics Market Forecast (2018-2023)

10.2.1.1. United States Point of Care Diagnostics Market Forecast (2018-2023)

10.2.1.2. Canada Point of Care Diagnostics Market Forecast (2018-2023)

10.2.1.3. Mexico Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.      Europe Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.1. Germany Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.2. United Kingdom Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.3. France Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.4. Russia Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.5. Italy Point of Care Diagnostics Market Forecast (2018-2023)

10.2.2.6. Rest of the Europe Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.      Asia-Pacific Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.1. China Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.2. Japan Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.3. Korea Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.4. India Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.5. Southeast Asia Point of Care Diagnostics Market Forecast (2018-2023)

10.2.3.6. Rest of Asia-Pacific Point of Care Diagnostics Market Forecast (2018-2023)

10.2.4.      South America Point of Care Diagnostics Market Forecast (2018-2023)

10.2.4.1. Brazil Point of Care Diagnostics Market Forecast (2018-2023)

10.2.4.2. Argentina Point of Care Diagnostics Market Forecast (2018-2023)

10.2.4.3. Columbia Point of Care Diagnostics Market Forecast (2018-2023)

10.2.4.4. Rest of South America Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.      Middle East and Africa Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.1. Saudi Arabia Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.2. UAE Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.3. Egypt Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.4. Nigeria Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.5. South Africa Point of Care Diagnostics Market Forecast (2018-2023)

10.2.5.6. Rest of MEA Point of Care Diagnostics Market Forecast (2018-2023)

10.3.    Point of Care Diagnostics Market Forecast by Product (2018-2023)

10.3.1.      Global Point of Care Diagnostics Revenue Forecast by Product (2018-2023)

10.3.2.      Global Point of Care Diagnostics Revenue Market Share Forecast by Product (2018-2023)

10.4.    Point of Care Diagnostics Market Forecast by End User (2018-2023)

10.4.1.      Global Point of Care Diagnostics Revenue Forecast by End User (2018-2023)

10.4.2.      Global Point of Care Diagnostics Revenue Market Share Forecast by End User (2018-2023)

10.5.    Point of Care Diagnostics Market Forecast by Technology (2018-2023)

10.5.1.      Global Point of Care Diagnostics Revenue Forecast by Technology (2018-2023)

10.5.2.      Global Point of Care Diagnostics Revenue Market Share Forecast by Technology (2018-2023)


List of Tables

*You can glance through the list of Tables and Figures when you view the sample copy of Point of Care Diagnostics Market.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*